NCT07250672Recruiting
Patient-Specific 3D Action Observation Training in Parkinson's Disease
Examining the Effect of Action Observation Training Using Patient-Specific 3D Records in Parkinson's Patients
Source: ClinicalTrials.gov · Last updated 11 May 2026
Brief summary (registry, in English)
Although studies exist demonstrating the effects of single-session action observation training on bradykinesia in patients with Parkinson's disease, research investigating the long-term application of such training remains limited. Furthermore, the broader literature indicates that action observation training has typically been conducted in simulated environments or by using recordings obtained from healthy individuals. The aim of the present study is to examine the effects of action observation training, delivered in a fully immersive virtual reality environment using each patient's own 3D motion recordings, on bradykinesia and other disease-related parameters.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- First submitted
- 2 Oct 2025
- Start date
- Dec 2025
- Primary completion date
- Jul 2027
- Lead sponsor
- Abant Izzet Baysal University
- Diseases
- Parkinson disease
- NCT number
- NCT07250672
What you commit to
- Study type: Interventional
- Planned participants: 24
- From Dec 2025 to the primary completion date, Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Change in medication dosage within the past month
Other illness
- Presence of additional neurological disorders other than Parkinson's disease
- Failure on the butterfly test of the Titmus stereotest (greater than 3,552 seconds of arc)
Other
- Score of ≥ 10 on the Simulator Sickness Questionnaire
- Presence of amblyopia, strabismus, or pathologies impairing focus, depth perception, or normal 3D vision
Who the study is looking for
- Voluntary agreement to participate in the study
- Clinical diagnosis of Parkinson's disease confirmed by a neurologist
- Ongoing treatment with antiparkinsonian medication
- Hoehn and Yahr (H-Y) stage ≤ 3
- Ability to walk independently
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Abant Izzet Baysal University Faculty of Health Science Coordinator of this site? Confirm its status | Bolu | Turkey (Türkiye) | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.